Clsi M47 -

CLSI M47 was created to address these gaps, providing a standardized framework for test selection, validation, quality control, and result interpretation.

For the laboratory, adhering to M47 is not just about passing accreditation—it is about diagnostic stewardship. A poorly validated PCR can lead to unnecessary antibiotics (false positive) or missed treatment (false negative). Conversely, a properly validated molecular test under M47 guidelines enables targeted therapy, reduced hospital stay, and improved antimicrobial resistance surveillance. clsi m47

| Parameter | Description | |-----------|-------------| | | Agreement between the new molecular method and a reference method (e.g., sequencing or reference lab). | | Precision (Repeatability & Reproducibility) | Intra-run and inter-run variability using positive and negative controls. | | Analytical Sensitivity (LoD) | The lowest concentration of bacterial DNA detectable ≥95% of the time. | | Analytical Specificity | Cross-reactivity with near-neighbor organisms and common flora. | | Inclusivity | Ability to detect genetic variants of the target organism. | | Exclusivity | No amplification of non-target organisms. | CLSI M47 was created to address these gaps,

Whether you are running a simple Group B Streptococcus PCR or a clinical metagenomics service, is your roadmap. It bridges the gap between powerful technology and trustworthy diagnosis, ensuring that when a report says “ Bordetella pertussis DNA detected,” clinicians and patients can act with confidence. Conversely, a properly validated molecular test under M47

The guideline is structured into logical sections that mirror the workflow of a molecular microbiology laboratory. Below are the most critical components.